Trusted When Accurate Intelligence Matters Most
Powering intelligence for millions of users at the world's most sophisticated firms
Trending News
What Is an Intelligence Engine?
Search Engines
"Where should I look?"
You type a query. You get a list of links. You read through them. You draw your own conclusions. Every time you need an update, you search again.
Reactive. Manual. You do the work.
Answer Engines
"What is the answer right now?"
You ask a specific question. You get a single response. It answers what you asked — nothing more. Tomorrow, you ask again.
Reactive. One-shot. No continuity.
Intelligence Engines
"What should I be paying attention to — and why?"
You define your focus once. Intelligence is synthesized from billions of sources across 100+ languages and delivered to you continuously — with full citations to original sources.
Proactive. Continuous. Intelligence that works for you.
Search engines retrieve. Answer engines respond. Intelligence Engines understand the world — continuously.
Intelligence That Comes to You.
Your Personal Daily Brief
The President's Daily Brief — for everyone.
Every morning, receive an AI-synthesized intelligence briefing built from your chosen topics and channels. Thousands of global sources — plus your own connected data like calendars and CRMs — distilled into the five minutes that matter most.
Your Morning Brief
Today's Briefing
Live Intel Agent
Listening...
"Tell me more about the SEC's new AI disclosure rules and how they might affect our compliance posture."
Based on your daily brief, the SEC proposed new rules requiring...
Intelligence Channels
Set your focus. We watch the world.
Create channels for any topic that matters to you — AI regulation, rare disease research, your competitor's moves, cryptocurrency markets. Define once, receive continuously.
The Intelligence Infrastructure Behind Every Insight.
Every briefing, every channel, every conversation with your Intel Agent is powered by the most comprehensive real-time intelligence infrastructure in the world.
Transforming the world's information into actionable insight.
Transforming the world's information into actionable insight.
Transforming the world's information into actionable insight.
Transforming the world's information into actionable insight.
Transforming the world's information into actionable insight.
FTS Studio: A Workspace Built for Builders.
Intelligence Workbench
Go Deeper Than Headlines
Analyze, compare, and synthesize intelligence with AI-powered tools. Dive deep into any topic across billions of documents and a decade of history.
AI Video Briefings
Turn Intelligence Into Video
Generate professional intelligence video briefings presented by an AI avatar. From topic selection to finished video in minutes.
Developer APIs & SDKs
Build Intelligence Into Everything
The same intelligence engine powering Personal Daily Briefs and Live Intel Agents — available to you as an API.
Your Agents. Your Models. Our Intelligence.
Build With Any Agent
Use our built-in AI agents or bring your own. Access 600+ language models through a single platform.
Intelligence for Every Domain
From Wall Street to the weekend warrior. From the boardroom to the breakfast table. Intelligence that fits your world.
Morning Intelligence Briefing
Start every day with an AI-synthesized brief covering exactly what you need to know — delivered before your first cup of coffee.
Market & Investment Intelligence
Stay ahead of market-moving events, earnings signals, and portfolio-relevant news across global markets in real time.
Regulatory & Compliance Monitoring
Monitor regulatory changes, policy shifts, and compliance deadlines globally — before they become emergencies.
Competitive Intelligence
Track competitor moves, product launches, leadership changes, and market positioning automatically across thousands of sources.
Your World, Connected
Connect your calendar, CRM, Slack, and internal docs — then watch your Daily Brief and Channels merge personal context with global intelligence.
AI-Powered Newsletters & Reports
Generate and distribute professional intelligence newsletters and reports to your team, clients, or subscribers. Zero manual effort.
Research & Deep Analysis
Synthesize intelligence across billions of documents and years of history. Stay current on academic publications, preprints, and breakthroughs.
Intelligence-Powered Applications
Build real-time intelligence into your products, dashboards, and AI agents using the same APIs that power this platform.
Every Insight. Every Source. Every Time.
Intelligence without attribution is noise. Every insight FinTech Studios delivers comes with clear citations to original sources, direct links to publisher websites, and full transparency about how conclusions were reached.
Live Updates
Farther Finance Advisors LLC Raises Stock Position in Strategy Inc $MSTR
Farther Finance Advisors LLC raised its position in Strategy Inc (NASDAQ:MSTR – Free Report) by 446% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC) The fund owned
Defenseworld
Apple At 50 — A Leadership Shift And An AR Future
Apple’s leadership shift and history of redefining tech point to AR glasses as its possible next major platform and potential driver of future growth.
Forbes
European Regulators Approve Moderna’s mRNA Influenza–COVID Vaccine
It's the first authorization for a combination shot against flu and COVID-19.
Theepochtimes
Massachusetts Financial Services Co. MA Invests $563,000 in Alpha and Omega Semiconductor Limited $AOSL
Massachusetts Financial Services Co MA purchased a new position in shares of Alpha and Omega Semiconductor Limited (NASDAQ:AOSL – Free Report) during the fourth quarter, according to the company in its most recent Form 13F
Defenseworld
ANÁLISISLa elección de Apple del sucesor de Tim Cook sugiere cuáles son sus planes para la era de la IA Apr 21, 2026
Ternus tendrá la tarea de trazar el próximo rumbo de Apple, y deberá hacerlo en un momento en que la inteligencia artificial (IA) está reconfigurando la tecnología y la manera en que las personas la utilizan en su día a día. El listón está especialmente alto para Apple, dado su historial de productos que han definido su categoría, entre los que se incluyen los teléfonos inteligentes, los relojes inteligentes y las tabletas.
Cnnespanol
Sanofi touts tolerability of COVID shot Nuvaxovid in head-to-head trial vs. Moderna's mNexspike
Sanofi’s protein-based vaccine Nuvaxovid has conquered Moderna’s next-generation messenger RNA shot mNexspike in a head-to-head trial assessing the tolerability of the two COVID vaccines.
Fiercepharma
Notice - John Hancock GA Mortgage Trust, et al.
John Hancock GA Mortgage Trust, et al., 20207-20208 [2026-07241] Agencies. SECURITIES AND EXCHANGE COMMISSION [Federal Register Volume 91, Number 72 (Wednesday, April 15, 2026)] [Notices] [Pages 20207-20208] From the Federal Register Online via the Government Publishing Office [www.gpo.gov] [FR Doc No: 2026-07241] ----------------------------------------------------------------------- SECURITIES AND EXCHANGE COMMISSION [Investment Company Act Release No. 36081; File No. 812-15828]
Regulations
Tim Cook names successor as he steps down as Apple CEO
Apple CEO Tim Cook is stepping down from the job that he inherited from the late Steve Jobs, ending a 15-year tenure that saw the company’s market value soar by more than €3.3 trillion during an iPhone-fuelled era of prosperity.
Euronews
Moderna wins EC nod for mCOMBRIAX
US biotech Moderna (Nasdaq: MRNA) today announced that the European Commission (EC) has granted marketing authorization for mCOMBRIAX (mRNA-1083), the company's mRNA combination vaccine for active immunization for the prevention of influenza disease and COVID-19 caused by SARS-CoV-2 in individuals 50 years of age and older. This article is accessible to registered users, to continue reading please register for free.
Thepharmaletter
Blackmon v. Blackmon 25-433 North Carolina Court of Appeals Opinion of the Court
An unpublished opinion of the North Carolina Court of Appeals does not constitute controlling legal authority. Citation is disfavored, but may be permitted in accordance with the provisions of Rule 30(e)(3) of the North Carolina Rules of Appellate Procedure. IN THE COURT OF APPEALS OF NORTH CAROLINA No. COA25-433. Filed 15 April 2026 Pitt County, No. 20CVD002234-730 KYLE FRANKLIN BLACKMON, Plaintiff, v. NANCY ANDERSON BLACKMON, Defendant.
Appellate
Why Tim Cook stepping down as CEO isn't shaking Jim Cramer's faith in Apple
Cramer isn't alone in his optimism: several Wall Street firms issued positive notes after the succession announcement.
Cnbc
Moderna receives EU approval for first flu-COVID combination vaccine
Moderna Inc. (NASDAQ: MRNA) announced the European Commission granted marketing authorization for mCOMBRIAX, its mRNA combination vaccine for influenza and COVID-19 prevention in individuals 50 years and older. The authorization follows a positive opinion from the European Medicines Agency's Committee for Medicinal Products for Human Use and applies to all 27 European Union member states, plus Iceland, Liechtenstein and Norway.
Streetinsider
Farther Finance Advisors LLC Raises Stock Position in Strategy Inc $MSTR
Farther Finance Advisors LLC raised its position in Strategy Inc (NASDAQ:MSTR – Free Report) by 446% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC) The fund owned
Defenseworld
Apple At 50 — A Leadership Shift And An AR Future
Apple’s leadership shift and history of redefining tech point to AR glasses as its possible next major platform and potential driver of future growth.
Forbes
European Regulators Approve Moderna’s mRNA Influenza–COVID Vaccine
It's the first authorization for a combination shot against flu and COVID-19.
Theepochtimes
Massachusetts Financial Services Co. MA Invests $563,000 in Alpha and Omega Semiconductor Limited $AOSL
Massachusetts Financial Services Co MA purchased a new position in shares of Alpha and Omega Semiconductor Limited (NASDAQ:AOSL – Free Report) during the fourth quarter, according to the company in its most recent Form 13F
Defenseworld
ANÁLISISLa elección de Apple del sucesor de Tim Cook sugiere cuáles son sus planes para la era de la IA Apr 21, 2026
Ternus tendrá la tarea de trazar el próximo rumbo de Apple, y deberá hacerlo en un momento en que la inteligencia artificial (IA) está reconfigurando la tecnología y la manera en que las personas la utilizan en su día a día. El listón está especialmente alto para Apple, dado su historial de productos que han definido su categoría, entre los que se incluyen los teléfonos inteligentes, los relojes inteligentes y las tabletas.
Cnnespanol
Sanofi touts tolerability of COVID shot Nuvaxovid in head-to-head trial vs. Moderna's mNexspike
Sanofi’s protein-based vaccine Nuvaxovid has conquered Moderna’s next-generation messenger RNA shot mNexspike in a head-to-head trial assessing the tolerability of the two COVID vaccines.
Fiercepharma
Notice - John Hancock GA Mortgage Trust, et al.
John Hancock GA Mortgage Trust, et al., 20207-20208 [2026-07241] Agencies. SECURITIES AND EXCHANGE COMMISSION [Federal Register Volume 91, Number 72 (Wednesday, April 15, 2026)] [Notices] [Pages 20207-20208] From the Federal Register Online via the Government Publishing Office [www.gpo.gov] [FR Doc No: 2026-07241] ----------------------------------------------------------------------- SECURITIES AND EXCHANGE COMMISSION [Investment Company Act Release No. 36081; File No. 812-15828]
Regulations
Tim Cook names successor as he steps down as Apple CEO
Apple CEO Tim Cook is stepping down from the job that he inherited from the late Steve Jobs, ending a 15-year tenure that saw the company’s market value soar by more than €3.3 trillion during an iPhone-fuelled era of prosperity.
Euronews
Moderna wins EC nod for mCOMBRIAX
US biotech Moderna (Nasdaq: MRNA) today announced that the European Commission (EC) has granted marketing authorization for mCOMBRIAX (mRNA-1083), the company's mRNA combination vaccine for active immunization for the prevention of influenza disease and COVID-19 caused by SARS-CoV-2 in individuals 50 years of age and older. This article is accessible to registered users, to continue reading please register for free.
Thepharmaletter
Blackmon v. Blackmon 25-433 North Carolina Court of Appeals Opinion of the Court
An unpublished opinion of the North Carolina Court of Appeals does not constitute controlling legal authority. Citation is disfavored, but may be permitted in accordance with the provisions of Rule 30(e)(3) of the North Carolina Rules of Appellate Procedure. IN THE COURT OF APPEALS OF NORTH CAROLINA No. COA25-433. Filed 15 April 2026 Pitt County, No. 20CVD002234-730 KYLE FRANKLIN BLACKMON, Plaintiff, v. NANCY ANDERSON BLACKMON, Defendant.
Appellate
Why Tim Cook stepping down as CEO isn't shaking Jim Cramer's faith in Apple
Cramer isn't alone in his optimism: several Wall Street firms issued positive notes after the succession announcement.
Cnbc
Moderna receives EU approval for first flu-COVID combination vaccine
Moderna Inc. (NASDAQ: MRNA) announced the European Commission granted marketing authorization for mCOMBRIAX, its mRNA combination vaccine for influenza and COVID-19 prevention in individuals 50 years and older. The authorization follows a positive opinion from the European Medicines Agency's Committee for Medicinal Products for Human Use and applies to all 27 European Union member states, plus Iceland, Liechtenstein and Norway.
Streetinsider
Frequently Asked Questions
Everything you need to know about FinTech Studios, your Personal Daily Brief, Live Intel Agent, and the Intelligence Engine.